USFDA announces more recalls of antacids containing
traces of carcinogen
To remove confusion the drug label must have NDMA free
Dr KK Aggarwal
President CMAAO< HCFI and Past National President IMA
In the last few years NDMA has, made more news. More and
more drugs are being withdrawn due to presence of this carcinogen. The pharma
companies should voluntarily mention on the label that their said molecule is
NDMA free.
The US Food and Drug Administration has recalled several
more lots of heartburn medications, Ranitidine that have been found to contain
trace amounts of a substance that may be linked to cancer. The WHO has
classified that substance, N-Nitrosodimethylamine (NDMA), as a "probable
human carcinogen. None of the recalled lots has been associated with any
injuries or adverse events.
It's
unclear whether such trace amounts of the carcinogens would cause harm when
taken as directed. FDA testing of recalled ranitidine detected NDMA levels
similar to the levels found in grilled and smoked meats.
Federal
regulators said other heartburn medications, such as famotidine, cimetidine, esomeprazole,
lansoprazole, and omeprazole have not tested positive for signs of NDMA.
No comments:
Post a Comment